Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase

被引:48
作者
Kaszuba, Karol [2 ,3 ]
Rog, Tomasz [2 ]
Danne, Reinis [2 ]
Canning, Peter [4 ]
Fueloep, Vilmos [4 ]
Juhasz, Tuende [5 ]
Szeltner, Zoltan [5 ]
St Pierre, J. -F. [6 ]
Garcia-Horsman, Arturo [7 ]
Mannisto, Pekka T. [7 ]
Karttunen, Mikko [8 ]
Hokkanen, Jyrki [9 ]
Bunker, Alex [1 ,10 ]
机构
[1] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland
[2] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland
[3] Univ Warmia & Mazury, Dept Phys & Biophys, Olsztyn, Poland
[4] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England
[5] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary
[6] Univ Montreal, Dept Phys & Regroupement Quebecois Mat Pointe, Montreal, PQ, Canada
[7] Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland
[8] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada
[9] CSC IT Ctr Sci Ltd, Espoo, Finland
[10] Aalto Univ, Sch Chem Technol, Dept Chem, Espoo, Finland
基金
芬兰科学院; 加拿大自然科学与工程研究理事会;
关键词
Prolyl oligopeptidase; Mutagenesis; Molecular dynamics; Crystallography; Gating mechanism; OXYANION BINDING-SITE; ENDOPEPTIDASE INHIBITOR; POTENTIAL FUNCTIONS; BETA-PROPELLERS; ACTIVE-SITE; SIMULATIONS; CATALYSIS; PEPTIDASE; JTP-4819; PROLINE;
D O I
10.1016/j.biochi.2012.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered prolyl oligopeptidase (PREP) activity is found in many common neurological and other genetic disorders, and in some cases PREP inhibition may be a promising treatment. The active site of PREP resides in an internal cavity; in addition to the direct interaction between active site and substrate or inhibitor, the pathway to reach the active site (the gating mechanism) must be understood for more rational inhibitor design and understanding PREP function. The gating mechanism of PREP has been investigated through molecular dynamics (MD) simulation combined with crystallographic and mutagenesis studies. The MD results indicate the inter-domain loop structure, comprised of 3 loops at residues, 189-209 (loop A), 577-608 (loop B), and 636-646 (loop C) (porcine PREP numbering), are important components of the gating mechanism. The results from enzyme kinetics of PREP variants also support this hypothesis: When loop A is (1) locked to loop B through a disulphide bridge, all enzyme activity is halted, (2) nicked, enzyme activity is increased, and (3) removed, enzyme activity is only reduced. Limited proteolysis study also supports the hypothesis of a loop A driven gating mechanism. The MD results show a stable network of H-bonds that hold the two protein domains together. Crystallographic study indicates that a set of known PREP inhibitors inhabit a common binding conformation, and this H-bond network is not significantly altered. Thus the domain separation, seen to occur in lower taxa, is not involved in the gating mechanism for mammalian PREP. In two of the MD simulations we observed a conformational change that involved the breaking of the H-bond network holding loops A and B together. We also found that this network was more stable when the active site was occupied, thus decreasing the likelihood of this transition. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1398 / 1411
页数:14
相关论文
共 73 条
[31]   Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease [J].
Mantle, D ;
Falkous, G ;
Ishiura, S ;
Blanchard, PJ ;
Perry, EK .
CLINICA CHIMICA ACTA, 1996, 249 (1-2) :129-139
[32]   RASTER3D VERSION-2.0 - A PROGRAM FOR PHOTOREALISTIC MOLECULAR GRAPHICS [J].
MERRITT, EA ;
MURPHY, MEP .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :869-873
[33]   Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders [J].
Momeni, Naghi ;
Nordstroem, Berit M. ;
Horstmann, Vibeke ;
Avarseji, Hassan ;
Sivberg, Bengt V. .
BMC PSYCHIATRY, 2005, 5 (1)
[34]   Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study [J].
Morain, P ;
Robin, JL ;
De Nanteuil, G ;
Jochemsen, R ;
Heidet, V ;
Guez, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (04) :350-359
[35]  
Morain P, 2002, CNS DRUG REV, V8, P31
[36]   Substrate recognition properties of oligopeptidase B from Salmonella enterica serovar typhimurium [J].
Morty, RE ;
Fülöp, V ;
Andrews, NW .
JOURNAL OF BACTERIOLOGY, 2002, 184 (12) :3329-3337
[37]   Efficient anisotropic refinement of macromolecular structures using FFT [J].
Murshudov, GN ;
Vagin, AA ;
Lebedev, A ;
Wilson, KS ;
Dodson, EJ .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1999, 55 :247-255
[38]   Influence of the disulfide bond configuration on the dynamics of the spin label attached to cytochrome C [J].
Murzyn, K ;
Róg, T ;
Blicharski, W ;
Dutka, M ;
Pyka, J ;
Szytula, S ;
Froncisz, W .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2006, 62 (04) :1088-1100
[39]   A MOLECULAR-DYNAMICS METHOD FOR SIMULATIONS IN THE CANONICAL ENSEMBLE [J].
NOSE, S .
MOLECULAR PHYSICS, 1984, 52 (02) :255-268
[40]   Processing of X-ray diffraction data collected in oscillation mode [J].
Otwinowski, Z ;
Minor, W .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :307-326